Effects of autofluorescence imaging on detection and treatment of early neoplasia in patients with barrett's esophagus

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 5, 2014, Pages 774-781

  Boerwinkel, David F ^a   Holz, Jasmin A ^a   Kara, Mohammed A ^a   Meijer, Sybren L ^a   Wallace, Michael B ^b   Wong Kee Song, Louis Michel ^c   Ragunath, Krish ^d   Wolfsen, Herbert C ^b   Iyer, Prasad G ^c   Wang, Kenneth K ^c   Weusten, Bas L ^e   Aalders, Maurice C ^a   Curvers, Wouter L ^a   Bergman, Jacques J G H M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Cancer Detection; Esophageal; Screening; Tumor

Indexed keywords

AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER SURGERY; COHORT ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; EARLY CANCER; ENDOSCOPIC SURGERY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; FOLLOW UP; HIGH GRADE INTRAEPITHELIAL NEOPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAMUCOSAL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; WHITE LIGHT ENDOSCOPY; CARCINOMA IN SITU; CLINICAL TRIAL (TOPIC); COMPLICATION; CYTOCHEMISTRY; ESOPHAGEAL NEOPLASMS; EVALUATION STUDY; FLUORESCENCE IMAGING; MIDDLE AGED; PROCEDURES; SENSITIVITY AND SPECIFICITY;

AGED; BARRETT ESOPHAGUS; CARCINOMA IN SITU; CLINICAL TRIALS AS TOPIC; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; OPTICAL IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 84899059542     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.10.013     Document Type: Article

References (20)

1. Haringsma J., Tytgat G.N., Yano H., et al. Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc 2001, 53:642-650.
2. Kara M.A., Peters F.P., Ten Kate F.J.W., et al. Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. Gastrointest Endosc 2005, 61:679-685.
3. Curvers WL, Singh R, Song L-MW-K, etal. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut 2008;57:167-172.
4. Boerwinkel D.F., Holz J.A., Aalders M.C.G., et al. Third-generation autofluorescence endoscopy for the detection of early neoplasia in Barrett's esophagus: a pilot study. Dis Esophagus 2013, Jun 24. Epub ahead of print.
5. Levine D.S., Haggitt R.C., Blount P.L., et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993, 105:40-50.
6. Curvers W.L., Herrero L.A., Wallace M.B., et al. Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett's esophagus. Gastroenterology 2010, 139:1106-1114.
7. Curvers W.L., van Vilsteren F.G., Baak L.C., et al. Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointest Endosc 2011, 73:195-203.
8. Boerwinkel D.F., Holz J., Aalders M., et al. First human feasibility study on third generation autofluorescence endoscopy for the detection of early neoplasia in Barrett's esophagus. Gastrointest Endosc 2012, 75. (4 Suppl)AB210.
9. Sharma P., Dent J., Armstrong D., et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006, 131:1392-1399.
10. Peters F.P., Kara M.A., Rosmolen W.D., et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. Am J Gastroenterol 2006, 101:1449-1457.
11. Pouw R.E., Seewald S., Gondrie J.J., et al. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients. Gut 2010, 59:1169-1177.
12. Gondrie J.J., Pouw R.E., Sondermeijer C.M.T., et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008, 40:370-379.
13. Pouw R.E., Wirths K., Eisendrath P., et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010, 8:23-29.
14. van Vilsteren F.G.I., Pouw R.E., Seewald S., et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011, 60:765-773.
15. Kerkhof M., van Dekken H., Steyerberg E.W., et al. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 2007, 50:920-927.
16. Downs-Kelly E., Mendelin J.E., Bennett A.E., et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol 2008, 103:2333-2340. quiz 2341.
17. Ormsby A.H., Petras R.E., Henricks W.H., et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002, 51:671-676.
18. Lundell L.R., Dent J., Bennett J.R., et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999, 45:172-180.
19. Boerwinkel D.F., Di Pietro M., Liu X., et al. Endoscopic trimodal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett's esophagus. Dis Esophagus 2012, Oct 15. Epub ahead of print.
20. Shariff K.M., di Pietro M., Boerwinkel D.F., et al. Time: a prospective study combining endoscopic trimodal imaging and molecular endpoints to improve risk stratification in Barrett's esophagus. Gastroenterology 2012, 142. (5 Suppl 1)S165.